OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
Parikshit Sen, Latika Gupta, James B Lilleker, et al.
Rheumatology International (2021) Vol. 42, Iss. 1, pp. 23-29
Open Access | Times Cited: 48
Parikshit Sen, Latika Gupta, James B Lilleker, et al.
Rheumatology International (2021) Vol. 42, Iss. 1, pp. 23-29
Open Access | Times Cited: 48
Showing 26-50 of 48 citing articles:
Attitudes and factors affecting decision‐making regarding COVID ‐19 vaccination among autoimmune rheumatic disease patients
Orathai Wantha, Ajanee Mahakkanukrauh, Kwankaew Tuydaung, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 4, pp. 751-758
Closed Access | Times Cited: 4
Orathai Wantha, Ajanee Mahakkanukrauh, Kwankaew Tuydaung, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 4, pp. 751-758
Closed Access | Times Cited: 4
Patients with idiopathic inflammatory myopathies suffer from worse self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort
Rajat Kharbanda, Keya Ganatra, Maryam Abbasi, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2269-2272
Open Access | Times Cited: 7
Rajat Kharbanda, Keya Ganatra, Maryam Abbasi, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2269-2272
Open Access | Times Cited: 7
Rheumatologists’ knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey
Hanan M. Fathi, Iman I. El‐Gazzar, Mervat I. Abd Elazeem, et al.
Rheumatology International (2022) Vol. 42, Iss. 6, pp. 989-998
Open Access | Times Cited: 6
Hanan M. Fathi, Iman I. El‐Gazzar, Mervat I. Abd Elazeem, et al.
Rheumatology International (2022) Vol. 42, Iss. 6, pp. 989-998
Open Access | Times Cited: 6
COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease
Monika Peshevska-Sekulovska, Plamena Bakalova, Violeta Snegarova, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2075-2075
Open Access | Times Cited: 6
Monika Peshevska-Sekulovska, Plamena Bakalova, Violeta Snegarova, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2075-2075
Open Access | Times Cited: 6
Incidence, features, and outcome of disease relapse after COVID ‐19 vaccination in patients with idiopathic inflammatory myopathies
Melinda Nagy‐Vincze, Tibor Béldi, Katalin Szabó, et al.
Muscle & Nerve (2023) Vol. 67, Iss. 5, pp. 371-377
Open Access | Times Cited: 3
Melinda Nagy‐Vincze, Tibor Béldi, Katalin Szabó, et al.
Muscle & Nerve (2023) Vol. 67, Iss. 5, pp. 371-377
Open Access | Times Cited: 3
To vaccinate or not to vaccinate: on vaccine hesitancy decreases in rheumatic diseases
Marco Krasselt
Lara D. Veeken (2023) Vol. 62, Iss. 10, pp. 3225-3226
Open Access | Times Cited: 3
Marco Krasselt
Lara D. Veeken (2023) Vol. 62, Iss. 10, pp. 3225-3226
Open Access | Times Cited: 3
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study
Nelly Ziadé, Marc Aoude, Ihsane Hmamouchi, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 657-664
Open Access | Times Cited: 3
Nelly Ziadé, Marc Aoude, Ihsane Hmamouchi, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 657-664
Open Access | Times Cited: 3
COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis
Haig Pakhchanian, Ahmad Saud, Rahul Raiker, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2257-2260
Open Access | Times Cited: 4
Haig Pakhchanian, Ahmad Saud, Rahul Raiker, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2257-2260
Open Access | Times Cited: 4
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study
Laura Andréoli, Daniele Lini, Karen Schreiber, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 5, pp. 1341-1351
Closed Access | Times Cited: 2
Laura Andréoli, Daniele Lini, Karen Schreiber, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 5, pp. 1341-1351
Closed Access | Times Cited: 2
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS
Maria D. LaRusso, C. Abadía
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 5, pp. 361-367
Open Access | Times Cited: 2
Maria D. LaRusso, C. Abadía
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 5, pp. 361-367
Open Access | Times Cited: 2
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey
Sakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 89-97
Closed Access | Times Cited: 2
Sakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 89-97
Closed Access | Times Cited: 2
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Leonardo Santos Hoff, R Naveen, Parikshit Sen, et al.
Lara D. Veeken (2024)
Open Access
Leonardo Santos Hoff, R Naveen, Parikshit Sen, et al.
Lara D. Veeken (2024)
Open Access
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
Leonardo Palazzo, Julius Lindblom, Emelie Kihlgren Olsson, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1923-1933
Open Access
Leonardo Palazzo, Julius Lindblom, Emelie Kihlgren Olsson, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1923-1933
Open Access
Digital approaches in myositis
Shinji Izuka, Parikshit Sen, Toshihiko Komai, et al.
Health Policy and Technology (2024) Vol. 13, Iss. 4, pp. 100906-100906
Closed Access
Shinji Izuka, Parikshit Sen, Toshihiko Komai, et al.
Health Policy and Technology (2024) Vol. 13, Iss. 4, pp. 100906-100906
Closed Access
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
Saadia Sasha Ali, Christiana A. Demetriou, Ioannis Parodis, et al.
Rheumatology Advances in Practice (2024) Vol. 9, Iss. 1
Open Access
Saadia Sasha Ali, Christiana A. Demetriou, Ioannis Parodis, et al.
Rheumatology Advances in Practice (2024) Vol. 9, Iss. 1
Open Access
Type 1 diabetes, COVID ‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study
Tulika Chatterjee, R Naveen, Narmadha Nair, et al.
Journal of Diabetes Investigation (2023) Vol. 15, Iss. 1, pp. 131-138
Open Access | Times Cited: 1
Tulika Chatterjee, R Naveen, Narmadha Nair, et al.
Journal of Diabetes Investigation (2023) Vol. 15, Iss. 1, pp. 131-138
Open Access | Times Cited: 1
The Impact of COVID-19 Vaccination on Autoimmune Disorders: A Descriptive Analysis
Aritra Ghosh, María M. Larrondo-Petrie, Mirjana Pavlović
(2023)
Open Access | Times Cited: 1
Aritra Ghosh, María M. Larrondo-Petrie, Mirjana Pavlović
(2023)
Open Access | Times Cited: 1
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group
Suhrud Panchawagh, R Naveen, Bhupen Barman, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 73-80
Open Access | Times Cited: 1
Suhrud Panchawagh, R Naveen, Bhupen Barman, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 73-80
Open Access | Times Cited: 1
New-Onset rheumatoid arthritis following ChAdOx1 nCoV-19 vaccine administration
Bhupen Barman, Debashis Priyadarshan Sahoo, Alvin Khangembam, et al.
Indian Journal of Rheumatology (2022) Vol. 17, Iss. 3, pp. 323-323
Open Access | Times Cited: 2
Bhupen Barman, Debashis Priyadarshan Sahoo, Alvin Khangembam, et al.
Indian Journal of Rheumatology (2022) Vol. 17, Iss. 3, pp. 323-323
Open Access | Times Cited: 2
Reply to “Letter to the Editor Regarding ‘COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis’”
Haig Pakhchanian, Rahul Raiker, Vikas Agarwal, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 60, pp. 152180-152180
Open Access
Haig Pakhchanian, Rahul Raiker, Vikas Agarwal, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 60, pp. 152180-152180
Open Access
UNMET NEED IN GERIATRICS – PATIENT VOICE
Mrudula Joshi, Kshitij Jagtap, Vikas Agarwal, et al.
Anti-Aging Eastern Europe (2023) Vol. 2, Iss. 2, pp. 118-121
Open Access
Mrudula Joshi, Kshitij Jagtap, Vikas Agarwal, et al.
Anti-Aging Eastern Europe (2023) Vol. 2, Iss. 2, pp. 118-121
Open Access
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset
Akira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 4, pp. 756-766
Open Access
Akira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 4, pp. 756-766
Open Access
COVID-19 et rhumatismes inflammatoires chroniques de l’adulte : le point après les vagues successives
Simon Cadiou, Marion Hervouet, Théau Cavillon, et al.
Revue du Rhumatisme (2023) Vol. 91, Iss. 3, pp. 327-337
Open Access
Simon Cadiou, Marion Hervouet, Théau Cavillon, et al.
Revue du Rhumatisme (2023) Vol. 91, Iss. 3, pp. 327-337
Open Access
